Seroprevalence of Herpes Simplex Virus Type 1 and Type 2 among Egyptian Children Aged from One to 15 Years old: A Comparative Study | |||||||||||||||||||||||||||||||||||||||||
Afro-Egyptian Journal of Infectious and Endemic Diseases | |||||||||||||||||||||||||||||||||||||||||
Article 10, Volume 12, Issue 4, December 2022, Page 383-389 PDF (315.83 K) | |||||||||||||||||||||||||||||||||||||||||
Document Type: Original Article | |||||||||||||||||||||||||||||||||||||||||
DOI: 10.21608/aeji.2022.168020.1260 | |||||||||||||||||||||||||||||||||||||||||
View on SCiNiTO | |||||||||||||||||||||||||||||||||||||||||
Author | |||||||||||||||||||||||||||||||||||||||||
Mahmoud RM El-Ansary | |||||||||||||||||||||||||||||||||||||||||
Department of Immunology and Medical Microbiology, Faculty of Medicine, Misr University for Science and Technology, Giza, Egypt. | |||||||||||||||||||||||||||||||||||||||||
Abstract | |||||||||||||||||||||||||||||||||||||||||
Background and study aim: Recent research has highlighted the importance of monitoring trends in herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) seroprevalence and their etiological surveillance. In this study, we aim to evaluate the seroprevalence of HSV1 and HSV2 among Egyptian children aged from one to 15 years old. Materials and Methods: This study was based on a sample of children who regularly attended Misr University for Science and Technology University hospital's outpatient clinics. The participants in the study ranged in age from 1 to 15 years old. An ELISA kit tested blood samples for HSV-1 and HSV-2 IgG and IgM. Results: In the present survey, 123 children were included. Overall, the median IgM and IgG values for the HSV type I study cohort were 0.39 (range, 0.0-3.07) and 1.50 (range, 0.02-3.89), respectively. The median IgM and IgG values for the HSV type II study cohort were 0.32 (range, 0.00-2.11) and 0.42 (range, 0.00-2.87), respectively. The prevalence of HSV type I among study candidates was 56.1%. However, the prevalence of type II was 4.1%. In comparison with the different age groups, it was found that the IgM levels in both HSV I and II have no difference (P-value = 0.701 and P-value = 0.576, respectively). In HSV I patients, there was a significant difference in IgG levels between age groups (P-value = 0.001), but no difference was found in HSV II patients (P-value = 0.870). Conclusion: HSV1 and HSV2 seroprevalence is prevalent among Egyptian children. | |||||||||||||||||||||||||||||||||||||||||
Highlights | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Keywords | |||||||||||||||||||||||||||||||||||||||||
Herpes Simplex Virus Type 1; HSV-1; Herpes Simplex Virus Type 2; HSV-2; Egypt | |||||||||||||||||||||||||||||||||||||||||
Supplementary Files
|
|||||||||||||||||||||||||||||||||||||||||
Full Text | |||||||||||||||||||||||||||||||||||||||||
INTRODUCTION The final stage of the liver's Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) are widespread human pathogens that can cause orolabial and vaginal infections, with the majority of infections occurring during childhood [1,2]. Mainly, HSV is asymptomatic and self-limited; however, in the presence of symptoms, ulcerative lesions develop at the infection site, particularly in neonates, young children, and immunocompromised hosts [3,4]. HSV-1 is traditionally considered a vesicular lesion pathogen. Nevertheless, increasing evidence suggests that adolescents and young adults develop genital HSV-1 infections [5]. HSV transmission from infected moms to newborns could result in significant neurological disorders or an increase in neonatal deaths [6]. Furthermore, in wealthy nations, HSV ocular infection is considered the most common cause of corneal blindness [7]. HSV infection can cause mild to severe diseases, including encephalitis, gingivostomatitis, and meningitis [8]. Moreover, a significant link between HSV infection and Alzheimer's disease and other dementias was proposed [9]. The global prevalence of HSV is 3.6 billion people infected orolabially and half a billion genitally [10]. Due to ongoing improvements in hygiene and living conditions, HSV-1 antibodies seroprevalence appears to be declining in western countries and around 30% among adolescents in the United States over the last three decades[11,12]. In the Middle East, it was estimated that the seroprevalence of HSV1 was 80.5% among Palestinians, 81.4% among Lebanese, 82.3% among Qataris, and 88.5% among Syrians, 92.6% among Yemenis, and 97.5% among Egyptians [13]. Furthermore, seroprevalence among Egyptians was continuously above 90% at all ages. Another study found that HSV1 and HSV2 were found in 80% of healthy Egyptian children [14]. These records highlight the importance of monitoring the trends in HSV1 and HSV2 seroprevalence and their etiological surveillance. As a result, this study aimed to determine the seroprevalence of HSV1 and HSV2 among Egyptian children aged 1 to 15 years old. MATERIALS AND METHODS Patients and study design:The present study follows the STROBE (Standards for Strengthening the Reporting of Observational Studies I Epidemiology) guidelines [15]. This study was based on a sample of children who attended outpatient clinics at Misr University for Science and Technology University hospital over time. The participants in the study ranged in age from 1 to 15 years old. Each participant had a venous blood sample obtained to determine blood lipid concentrations. At room temperature, the blood samples were allowed to coagulate. After that, each sample was centrifuged two hours after harvesting. The serum was then transferred to a storage container and stored at -20°C. Serologic testing:ELISA was used to test blood samples for HSV-1 and HSV-2 IgG and IgM, as per the manufacturer's recommendations (HerpeSelect, Focus Technologies, Inc., Cypress, CA) [16]. After centrifugation, samples with index values between 0.8 and 1.2 were re-evaluated using the sample supernatant (15000 rpm for 5 min on an Eppendorf 5804 microfuge). Because it was regulated using a reference serum that the manufacturer had modified to obtain a cut-off value that was erroneously assigned the Index value of 1, the OD was incorrectly assigned the Index value of 1. An immunoblot was utilised to eliminate undecided samples (HerpesSelect 1 & 2 Immunoblot, Focus Technologies, Inc). Statistical analysis: SPSS version 22.0 for Windows was used to analyse the data. The mean and standard deviation were used to determine the results (SD). The Kolmogorov-Smirnov test was used to determine the normality for continuous variables. A P-value of less than 0.05 was considered statistically significant (two-sided testing). A one-way ANOVA test was used to compare the outcomes of the different age groups' tests. The Chi-square test was used to examine if there were any significant differences between proportions and categorical variables. RESULTS In this survey, the 123 children approved the participation and were included in this study through our outpatient clinic in Misr University for Science and Technology University hospital's outpatient clinics. The study Cohort was segmented regarding age groups into three groups. Group one had children under five years old (n = 41). Group two included children aged between five and ten (n = 41). Group three included children aged more than ten and less than fifteen years old (n = 41). Seroprevalence of HSV Type I and Type II:Overall, the median IgM and IgG values for the HSV type I study cohort were 0.39 (range, 0.0-3.07) and 1.50 (range, 0.02-3.89), respectively. The median IgM and IgG values for the HSV type II study cohort were 0.32 (range, 0.00-2.11) and 0.42 (range, 0.00-2.87), respectively. The prevalence of HSV type I among study candidates was 56.1%. However, the prevalence of type II was 4.1% (Figure 1). Seroprevalence of HSV and age groups:Regarding age group one (less than five years old), the median IgM and IgG values of HSV type I was 0.35 (range, 0.00 - 2.11) and 0.54 (range, 0.02 - 2.70), respectively. In HSV type II, the median IgM and IgG were 0.30 (range, 0.00 - 0.81) and 0.41 (range, 0.00 - 0.94), respectively. The prevalence of HSV type I in this group was 17.1%. However, the prevalence of type II was 0.0%. Concerning the second group (five to ten years old), the median IgM and IgG values of HSV type I were 0.30 (range, 0.01 - 3.00) and 1.33 (range, 0.03 - 3.87), respectively. In HSV type II, the median IgM and IgG were 0.42 (range, 0.01 - 0.85) and 0.45 (range, 0.03 - 0.85), respectively (Table 1). In this group, the prevalence of HSV type I was 61.0%. However, the prevalence of type II was 0.0%. Regarding group three (more than ten and less than fifteen years old), the median IgM and IgG values of HSV type I were 0.40 (range, 0.01 - 3.07) and 2.56 (range, 0.12 - 3.89), respectively. In HSV type II, the median IgM and IgG were 0.29 (range, 0.00 - 2.11) and 0.34 (range, 0.01 - 2.87), respectively. The prevalence of HSV type I among this group was 90.2%. However, the prevalence of type II was 12.2% (Table 2). Compared with the different age groups, the IgM levels in both HSV I and II have no difference (P-value = 0.701 and P-value = 0.576, respectively). Regarding IgG levels, there was a significant difference between the different age groups for HSV I (P-value = 0.001). However, no difference was detected in HSV II patients (P-value = 0.870). Table (1): The serum levels of IgM and IgG of HSV in the study cohort.
Table (2): The prevalence of HSV in the different age groups
DISCUSSION In this observational study, we evaluated the seroprevalence of HSV-1 and HSV-2 in Egyptian children, which proved to be widespread, especially among those over the age of ten. This is the first Egyptian study that we are aware of that looked at HSV seroprevalence in healthy children. Loutfy et al. [14], The seroprevalence of HSV-1 and 2 (IgG) was 69% in children with acute leukaemia and 80% in the standard control group. Moreover, they found that the prevalence was higher in children aged 5-10 years and older than ten years, supporting our findings. On the other hand, they showed that the prevalence was comparable between both genders (70% in males and 66.6% in females). Regarding HSV-2, we found that the prevalence in children for more than ten years and less than 15 years was 12.2%. According to large-scale studies in Asia, the overall prevalence of HSV-2 seropositivity is around 10% [17,18]. A seropositive HSV-2 prevalence of 15 to 29% was reported in several investigations around the end of the twentieth century. However, these studies were largely hospital-based or focused on the adult population[19–21]. Many studies were conducted in the Middle East to estimate the seroprevalence of HSV; however, the data regarding healthy children were scanty. In Netherlands, the seroprevalence of HSV-1 ranged between 42.7% to 47.7% [22]. The authors have also found that adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity. In another study conducted by Woestenberg et al. [23], Adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity. In the middle East and North African male populations residing in Qatar, country-specific HSV-1 seroprevalence was estimated for 10 national populations: 97.5% among Egyptians, 92.6% among Yemenis, 90.7% among Sudanese, 88.5% among Syrians, 86.5% among Jordanians, 82.3% among Qataris, 81.4% among Iranians, 81.4% among Lebanese, 80.5% among Palestinians, and 77.0% among Pakistanis[23]. Seroprevalence increased with age among Fertile Crescent and Qatari nationals. Seroprevalence increased from 70.0% among those aged ≤ 24 years up to 98.0% among those aged ≥55 years among Fertile Crescent nationals [23]. According to a recent comprehensive analysis, HSV-1 seroprevalence was 65 % in Middle Eastern youngsters[24]. This high level of HSV-1 indicates considerable HSV-1-related morbidity in these populations. The bulk of Middle East studies found seroprevalence increases with age at younger ages, which was consistent with most infections occurring in childhood. The average seroprevalence in Asian children was over 60%, while in adults, seroprevalence was roughly 30% higher than in children [25–27]. The age of children was also the strongest predictor of HSV-1 seroprevalence [28]. Although socioeconomic conditions can affect the prevalence of HSV-1, Chaabane et al. showed that 44% of the variation in seroprevalence is due to age [24]. According to Yousuf et al. [29], age accounts for roughly half of the range in seroprevalence in other countries, with the striking exception of Africa, where age accounts for 80% of the variation [29]. However, the role of early speculation cannot be neglected, especially in children. The situation is slightly different in adults; young people had much lower HSV-1 seroprevalence than older adults [24]. Remarkably, In the Middle East and North Africa (MENA) region, there was inadequate evidence for HSV-1 sexual transmission to play a role. According to Chaabane et al., they were unable to find a single study in this region that looked into the role of HSV-1 in the aetiology of genital herpes[24]. However, in North America, the detection of HSV-1 in genital herpes was 34% higher than HSV-2 [25]. The differences in sexual culture between North America, Europe, and MENA can be attributed to differences in sexual transmission. The most common route for HSV-1 infection in early infants may be via non-sexual transmission. The most common mechanism of viral transmission among people was close contact between young children (for example, in daycare centres or among family members) and adults and children. HSV-1 serostatus may be affected by childhood hygiene and living conditions as well [30]. In wealthy countries, seroprevalence was found to be lower, showing a global link between HSV-1 infection and socioeconomic position [31]. Compared to those wealthy countries in MENA, such as Iran, Jordan, and Qatar, low to middle-income countries like Egypt, Sudan, and Yemen had the highest seroprevalence [32]. Asia's faster modernisation can explain this disparity between the Middle East and North Africa. This epidemiological situation may end up constituting a public health risk. Genital herpes has been related to a higher risk of HIV infection [33]. Second, pregnant women with primary genital herpes can transfer HSV-1 to their newborns during labour and delivery, and neonatal HSV infections have a high risk of significant morbidity [34,35]. A rise in the frequency of ocular infection, in addition to vaginal infection, may be connected to age-specific HSV-1 seroprevalence [9]. Recommendations: Since we evaluate only the seroprevalence of HSV1 and HSV2 among Egyptian children aged from one to 15. We recommend adding more questions in sociodemographic data to be more valuable in the study to find its relation to the seroprevalence of HSV1 and HSV2 among Egyptian children aged 1 to 15. Also, larger study with bigger sample sizes should be the logical forward step following the currently available literature. In conclusion, HSV-1 and HSV-2 seroprevalence is high in Egypt, particularly among older children (10-15 years old), highlighting the necessity for ongoing surveillance of HSV-1 and 2 seroprevalences, as well as etiological surveillance of linked morbidities. Acknowledgement: None Funding Sources: None Ethical considerations: All participants were required to sign a consent before withdrawing the blood samples. This consent involves the potential risk and the detailed information about the study but not principally for the assays of Herpes simplex antibodies. The Institutional Review Board of MUST University authorised the usage of these serum samples. | |||||||||||||||||||||||||||||||||||||||||
References | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Statistics Article View: 1,137 PDF Download: 422 |
|||||||||||||||||||||||||||||||||||||||||